All analyses
AI analysis

Hemas Holdings Ltd.: research report

Moderately undervaluedbullishNov 12, 2026

Evidence points bullish: the shares are moderately undervalued while September revenue grew 17.1%. The catch is that net profit fell as margins and finance costs worsened.

Today's public report is ready. The next one can be generated tomorrow. Add a focus below for your own private research.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • September-quarter revenue rose 17.1%, while operating profit still increased 8.1%, preserving underlying earnings growth despite pressure below operating profit.
  • The latest audited year generated a 15.7% return on equity, supporting the premium to book value.
  • Hemas has completed a 75% acquisition of Twiga, extending its Consumer Brands platform into East Africa; the announcement did not disclose Twiga earnings, so its contribution cannot yet be sized.

Against this. September-quarter net profit fell 1.7% as net margin contracted to 5.6% from 6.7%.

Operating margin
10.0%sector 9.7%
from 10.8% a year earlier
Net margin
5.6%sector 3.0%
from 6.7% a year earlier, revenue +17.1%
Return on equity
15.0%
twelve months to Sep 30, 2026, unaudited
P/E
11.4sector 14.2
earnings Rs 2.87 per share, year to Sep 2026
P/B
1.71sector 1.20
book Rs 19.22 per share
Dividend yield
3.05%sector 2.08%
34.8% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 12, 2026. Sector figures are the median of 22 listed companies in the same sector.

Overview

Hemas is a diversified group spanning healthcare, consumer brands, mobility, leisure, travel, aviation, logistics and maritime services. The September quarter showed stronger sales and operating profit, but the benefit did not reach shareholders because lower margins and higher costs below operating profit reduced net profit.

The completed Twiga acquisition adds an East African consumer platform to Atlas Axillia. Its disclosed purchase price and 75% ownership establish the scale of the transaction, but no acquired revenue or profit was disclosed, so its effect on group earnings remains unmeasured.

Price performance

At LKR 33.00 on 11 November 2026, HHL had risen 9.2% over one month, close to the ASPI's 9.7% gain, while its 6.7% three-month return exceeded the index's 2.9%. The share was 62.4% of the way from its 52-week low to high, placing it above the midpoint of its own annual range rather than at either extreme.

The record since November 2023 contains two falls of 15% or more, the deepest 24%, which took seven months to recover. Median daily turnover was LKR 5.0 million; a LKR 1 million order is about 20% of what trades on a typical day, a noticeable part of a day's trading.

Valuation

At 11.1 times earnings, the share asks for about LKR 11 for each LKR 1 of trailing profit, below the diversified-holdings median of 14.83 times and cheaper than 62% of days since January 2019. The current price therefore values Hemas below the typical sector earnings multiple, although it is not unusually cheap against its own P/E record.

The 1.72 times P/B means paying LKR 1.72 for each LKR 1 of net assets, above the sector median of 1.20 and more expensive than 77% of days since January 2019. That premium is partly reconciled by the latest audited 15.7% return on equity. A 3.0% dividend yield is above the sector median, and the payout rose from LKR 0.90 in FY2025 to LKR 1.00 in FY2026.

A buyer at this price relies partly on the latest quarter, which supplied 23.4% of trailing EPS. If that quarter had retained its year-ago net margin, the same price would stand on 10.6 times earnings rather than 11.1 times.

News and sentiment

Direct coverage was normal rather than unusually loud: 25 material articles in the last 90 days included 12 positive, 10 negative and three neutral items. The main news tension is clear in the 6 November results coverage: second-quarter revenue and EBITDA improved, but reported earnings fell because working-capital borrowing and the Twiga acquisition raised finance costs.

Articles reported on 17 and 18 August confirmed the 75% acquisition of Kenya's Twiga Stationers and Printers for US$16.2 million. A LKR 0.25 first interim dividend has a confirmed ex-date of 16 November 2026 and payment date of 4 December 2026.

Financials

September-quarter revenue rose 17.1% to LKR 37.8 billion and operating profit increased 8.1%, but net profit fell 1.7% to LKR 2.1 billion. Gross margin was 29.7% versus 32.8% a year earlier, operating margin was 10.0% versus 10.8%, and net margin was 5.6% versus 6.7%. In everyday terms, the group retained about 6 cents of profit from each LKR 1 of sales, down from nearly 7 cents a year earlier.

The latest September gross margin ranked a middling fifth of eight comparable September quarters, operating margin ranked fourth of eight, and net margin third of eight. This was therefore not an extreme September print in the company's own record, despite the year-on-year margin compression.

Operating profit exceeded net profit by LKR 1.7 billion in the quarter, compared with a smaller drag a year earlier. Finance costs alone rose to LKR 464 million from LKR 186 million, explaining why the sales and operating-profit gains did not translate into higher shareholder profit. The latest audited full year, ended March 2026, recorded revenue growth of 8.0% and net-profit growth of 11.4%.

Risks

The principal risk is that borrowing and funding costs have risen sharply since the March audited balance sheet. September total debt was LKR 18.4 billion, versus LKR 6.1 billion at March, while the quarter's finance cost was LKR 464 million. This is material because the latest quarter's operating improvement was outweighed below the operating-profit line.

The March balance sheet was nevertheless conservatively financed, with gearing of 10.8% of owners' equity and interest cover of 13.79 times, meaning operating profit covered the interest bill nearly fourteen times. Its current ratio was 1.72, or LKR 1.72 of short-term assets for every LKR 1 of bills due within a year. Cash conversion was 0.83 times, so not all operating profit arrived as cash during that audited year.

Healthcare represents 62% of reported segment revenue, while consumer retail represents 38%. The broader backdrop includes 8.3% October inflation and higher fuel prices, conditions that can pressure household spending and operating costs, though the supplied data does not quantify Hemas-specific effects.

Outlook

As at 12 November 2026, the next scheduled evidence is the interim quarter ending 31 December 2026, expected to be filed between 4 and 14 February 2027. It will replace the September data and show whether the stronger second-quarter revenue run rate is converting into shareholder profit after finance costs and the Twiga acquisition.

The confirmed LKR 0.25 interim dividend goes ex-dividend on 16 November 2026; only a buyer before that day receives it. The available data cannot yet separate Twiga's earnings contribution, integration costs or funding effect from Hemas's existing businesses.

About this report. Generated on Nov 12, 2026 from market data up to Nov 11, 2026, 25 material news articles over 90 days and financials to Sep 30, 2026, and scored 63 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports